Skip to main content
SpringerLink
Log in

Direct and Indirect Costs of Cardiovascular and Cerebrovascular Complications of Type II Diabetes

  • Published:
PharmacoEconomics Aims and scope Submit manuscript

Summary

Macroangiopathy (atherosclerosis) is a common chronic complication in non-insulin-dependent diabetes mellitus (NIDDM, type II diabetes) with a significant attendant mortality and morbidity. While there are inherent difficulties in estimating the economic burden of large vessel disease in type II diabetes, this has been attempted in several studies by use of insurance claims, hospital inpatient statistics, and extrapolation from standard mortality data. This evidence suggests that the macrovascular complications of type II diabetes (ischaemic heart disease, peripheral vascular disease, and cerebrovascular disease) account for approximately one-third of all healthcare expenditures and one-quarter of disability related to type II diabetes in developed countries. The large and growing economic burden of these complications of diabetes in developing countries is unknown.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Barrett-Connor E, Orchard T. Diabetes and heart disease. In: National Diabetes Data Group. Diabetes in America: Diabetes data compiled 1984. Bethesda, Md. National Institutes of Health: 1985: Chapter 16. Publication 85–1468

    Google Scholar 

  2. Marks HH, Krall LP. Onset, course, prognosis and mortality in diabetes mellitus. In: Marble A, et al.. editors. Joslin’s diabetes mellitus. 11th ed. Philadelphia: Lea and Febiger, 1971: 209–54

    Google Scholar 

  3. World Health Organization. Diabetes Mellitus. Report of a WHO study group. WHO Technical Report Series. World Health Organization, Geneva: 1985: 727

    Google Scholar 

  4. Jonsson B. Diabetes — the cost of illness and the cost of control. Acta Med Scan 1983; 671 Suppl. 1: 19–27

    CAS  Google Scholar 

  5. Triomphe A, Flori YA, Costagliola A, et al. The cost of diabetes in France. Health Policy 1988; 9: 39–48

    Article  PubMed  CAS  Google Scholar 

  6. McKendry JBR. Direct costs of diabetes care: a survey in Ottawa, Canada. Can J Public Health 1989; 80: 124–8

    PubMed  CAS  Google Scholar 

  7. Weinberger M, Cowper PA, Kirkman MS, et al. Economic impact of diabetes in the elderly. Clin Geriat Med 1990; 6: 959–71

    CAS  Google Scholar 

  8. Triomphe A. Economic analysis and public health. In: The economic burden of diabetes. Diabete Metab 1993; 9: 473–6

    Google Scholar 

  9. Rendell M, Kimmel DB, Bamisedun O. et al. The health care status of the diabetic population as reflected by physician claims to a major insurer. Arch Intern Med 1993; 153 (II): 1360–6

    Article  PubMed  CAS  Google Scholar 

  10. Aro S, Kangas T, Reunanen A, et al. Hospital use among diabetic patients and the general population. Diabetes Care 1994; 17: 1320–9

    Article  PubMed  CAS  Google Scholar 

  11. Williams DRR. Hospital services by elderly diabetic patients: information from hospital activity analysis. Diabet Med 1985; 2: 27–32

    Article  PubMed  Google Scholar 

  12. Green A, Solander F. Epidemiological studies of diabetes mellitus in Denmark. Use of hospital services by insulin-treated patients. Diabetologia 1984; 26: 195–6

    PubMed  CAS  Google Scholar 

  13. Damsgaard EM, Frøland A, Green A. Use of hospital services by elderly diabetics: the Frederica study of diabetic patients and fasting hyperglycaemic patients aged 60–74 years. Diabet Med 1987; 4: 317–22

    Article  PubMed  CAS  Google Scholar 

  14. Kosonen K, Valkama N. The cost of diabetes to society in Finland in 1989. Master’s thesis, University of Kuopio, Kuopio, Finland: 1993

    Google Scholar 

  15. Jacobs J, Sena M, Fox N. The cost of hospitalization for the late complications of diabetes in the United States. Diabet Med 1991; 8 Spec No: S23–9

    Article  Google Scholar 

  16. Huse DM, Oster G, Killen AR, et al. The economic costs of non-insulin dependent diabetes mellitus. JAMA 1989; 262: 2708–13

    Article  PubMed  CAS  Google Scholar 

  17. Harris MI, Hadden WC, Knowlert WC, et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the US population aged 20–74 yr. Diabetes 1987; 36: 523–34

    Article  PubMed  CAS  Google Scholar 

  18. Harris MI, Hadden WC, Knowlert WC, et al. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in the US population aged 20–74 yr. Diabetes 1987; 36: 523–34

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Vascular Medicine, Diabetes Research, Postgraduate Medical School, Exeter, England

    Kenneth M. MacLeod (Senior Registrar) & John E. Tooke

Authors
  1. Kenneth M. MacLeod
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. John E. Tooke
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

MacLeod, K.M., Tooke, J.E. Direct and Indirect Costs of Cardiovascular and Cerebrovascular Complications of Type II Diabetes. Pharmacoeconomics 8 (Suppl 1), 46–51 (1995). https://doi.org/10.2165/00019053-199500081-00010

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00019053-199500081-00010

Keywords

Search

Navigation